NasdaqGS - Nasdaq Real Time Price USD
Amphastar Pharmaceuticals, Inc. (AMPH)
23.75
-0.36
(-1.49%)
As of 10:59:55 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 5 | 6 |
| Avg. Estimate | 0.74 | 0.82 | 3.06 | 3.54 |
| Low Estimate | 0.6 | 0.76 | 3.01 | 3.14 |
| High Estimate | 0.81 | 0.98 | 3.14 | 3.74 |
| Year Ago EPS | 0.94 | 0.96 | 3.86 | 3.06 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 5 | 6 |
| Avg. Estimate | 174.28M | 186.89M | 721.9M | 765.31M |
| Low Estimate | 161M | 178M | 714M | 747.3M |
| High Estimate | 182M | 195.87M | 730.8M | 803M |
| Year Ago Sales | 182.39M | 191.21M | 731.97M | 721.9M |
| Sales Growth (year/est) | -4.45% | -2.26% | -1.38% | 6.01% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.75 | 0.98 | 0.94 | 0.69 |
| EPS Actual | 0.94 | 0.96 | 0.92 | 0.74 |
| Difference | 0.19 | -0.02 | -0.02 | 0.05 |
| Surprise % | 25.08% | -2.13% | -1.95% | 7.61% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.74 | 0.82 | 3.06 | 3.54 |
| 7 Days Ago | 0.72 | 0.84 | 3.16 | 3.75 |
| 30 Days Ago | 0.73 | 0.82 | 3.16 | 3.74 |
| 60 Days Ago | 0.71 | 0.79 | 3 | 3.84 |
| 90 Days Ago | 0.88 | 1.01 | 3.79 | 4.34 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 2 | 1 |
| Up Last 30 Days | 1 | 2 | 2 | 2 |
| Down Last 7 Days | -- | 2 | 2 | 3 |
| Down Last 30 Days | -- | 2 | 2 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AMPH | -21.72% | -14.29% | -20.73% | 15.54% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Downgrade | JP Morgan: Overweight to Neutral | 5/12/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 5/8/2025 |
| Reiterates | Needham: Hold to Hold | 4/10/2025 |
| Maintains | Piper Sandler: Neutral to Neutral | 3/21/2025 |
| Downgrade | Piper Sandler: Overweight to Neutral | 2/4/2025 |
| Initiated | Wells Fargo: Overweight | 11/22/2024 |
Related Tickers
COLL Collegium Pharmaceutical, Inc.
29.78
+3.08%
PCRX Pacira BioSciences, Inc.
25.43
+1.23%
PBH Prestige Consumer Healthcare Inc.
87.26
-0.05%
LFCR Lifecore Biomedical, Inc.
6.75
-3.16%
AMRX Amneal Pharmaceuticals, Inc.
7.54
+1.69%
ANIK Anika Therapeutics, Inc.
12.19
+4.72%
SUPN Supernus Pharmaceuticals, Inc.
31.73
+0.09%
RDY Dr. Reddy's Laboratories Limited
13.84
+3.28%
KNSA Kiniksa Pharmaceuticals International, plc
26.42
+1.50%
UTHR United Therapeutics Corporation
304.74
+1.10%